Surgical Site Infection

Meet the patient

A 64-year-old diabetic man is on day 7 after a sigmoid colectomy for cancer. The SHO calls you to the ward because the wound has "started to weep". The lower third of the incision is angry red, hot, and draining thick yellow pus that has soaked through the dressing. He has a low-grade fever and his CRP, which had been falling, has climbed back up.^[1]

Two questions now decide his next hour, and they decide every SSI: how deep does this go? (the bedside exam and imaging tell you), and is this simple cellulitis or a collection needing a knife? (the depth and the pus tell you). Hold those two questions and the whole topic slots into place.^[3]

What SSI is — 30 days, 90 days, and a definition that dates to 1992

Surgical site infection is any infection at or near the incision, or in any deep organ or space manipulated at operation, arising within 30 days — or within 90 days if an implant is in place. The implant list to memorise: prosthetic joint, vascular graft, mesh, cardiac device, breast prosthesis. The clock starts at the operation, not at discharge.^[3]

The operational definition every surveillance programme still uses is Horan et al. 1992, reaffirmed unchanged by the CDC 2017 Prevention Guideline (Berríos-Torres). A wound is an SSI if any one of five things is true, and you should be able to recite them at viva:^[3]

^[3]

The classic trap: purulent drainage alone is SSI by CDC criteria — you do not need a fever, a raised CRP, or a positive culture to call it. If the wound is weeping pus within 30 days, it is an SSI until proven otherwise, and the surgeon who waits for the "full picture" has already delayed source control.^[3]

Three depths — "skin, fascia, or cavity"

Depth is the single most important bedside distinction, because depth decides the management. Everything turns on one question: is the infection confined to the body wall, or has it reached a deeper cavity or organ? Body-wall infection you can open and dress; cavity infection needs imaging, drainage, and often re-operation.^[1]

^[1]

The one-line discriminator to carry into the viva: superficial you can see and dress; deep you must open; organ-space you must drain or re-operate. The depth, not the organism, sets the first move.^[1]

The wound-contamination ladder — clean under 2 to dirty over 27

Before you ever cut, the predicted SSI rate is set by what you are about to contaminate. The four-class wound scheme — originally the National Research Council in 1964, refined by CDC — predicts baseline risk and tells you which antibiotic to choose. Know the percentages cold; examiners love them.^[2]

^[2]

The number rule to memorise: clean under 2, clean-contaminated 3 to 7, contaminated 10 to 15, dirty over 27. A clean wound that becomes infected should make you ask what broke — usually the prophylaxis timing, the technique, or the patient's defences.^[2]

The NNIS risk index — A, C, W (ASA, Contaminated, Wall-clock)

Raw SSI rates lie, because dirty cases infect more than clean ones. To compare surgeons and hospitals fairly you adjust for case-mix with the NNIS or NHSN risk index — a 0 to 3 score that adds one point for each of three things. A patient scoring 3 carries up to a ten-fold higher SSI risk than one scoring 0, which is why NNIS-adjusted rates underpin public reporting in the USA and NHSN surveillance.^[2]

^[2]

The 75th-percentile cutoff is published per procedure in NHSN tables, so "long" for a hernia is not "long" for a Whipple. The score is the framework examiners want when they ask how you would compare two surgeons' infection rates honestly.^[1]

Enlarge

How common, and who pays — the preventable burden

SSI is the commonest nosocomial infection in surgical patients, and most of it is preventable. In the CDC NHSN 2014 multistate point-prevalence survey, healthcare-associated infection prevalence in US acute-care hospitals was about 4 percent, and SSI carried a major share in surgical patients. The WHO guideline notes that SSIs are the most common healthcare-associated infections in developing countries.^[4]

The harm is not subtle. In the English NINSS series (Coello et al., 2832 SSIs after 67 410 procedures in 140 hospitals), extra postoperative stay attributable to SSI ranged from 3.3 to 21.0 days and was at least nine days in most surgical categories, at a cost of £959 to £6103 per episode; adjusted mortality was significantly raised for SSI after hip prosthesis (odds ratio 1.8) and for deep or organ or space SSI after vascular surgery (odds ratio 6.8).^[18]

Consultant confession: when a ward round is shortened by an SSI, the patient pays in days and disability and the hospital pays in pounds — and almost all of it was sitting in a checklist that somebody skipped. The economics are why prevention is funded, but the patient is why it matters.^[18]

Who gets it — the patient risks you screen for in clinic

Some patients arrive infected before the first cut. The high-yield list, in the order you should screen for it at pre-assessment, with the numbers the studies actually give you:^[1]

^[1]

The ones you can act on before the date — glycaemic control, weight, and decolonising known S. aureus carriers — are the ones that turn a high-risk patient into a lower-risk one.^[13]

The procedure risks you control on the day

On the operating list, the surgeon and the team own most of the remaining risk. These are the levers, and most of them map directly onto the prevention bundle further down:^[2]

• Wound class — clean to dirty, the ladder above; you cannot change it, but you plan for it.^[2]
• Operation duration — risk climbs roughly linearly with time on the table.
• Approach — laparoscopic and minimally invasive surgery carries a lower SSI rate than open.^[1]
• Prophylactic antibiotic timing and choice — the single most evidence-backed lever, and the one most often missed.^[6]
• Perioperative hypothermia — a core temperature under 36 degrees Celsius doubles the SSI rate.^[10]
• Perioperative hypoxia, hypotension, inadequate resuscitation, and blood transfusion.^[11]
• Hair removal by shaving — the razor makes micro-lacerations; clip instead.^[16]
• Poor glycaemic control — even non-diabetics with stress hyperglycaemia are at risk.^[1]
• Foreign material — sutures, drains, mesh, and prosthesis all lower the inoculum threshold for infection.
• Surgical technique — rough tissue handling, excessive diathermy, haematoma, dead space, and hypoperfusion all invite trouble.

Why it happens — inoculum versus host defence, and the biofilm trap

Enlarge

An SSI is a balance tipped: the bacterial load and virulence at the site overcome the patient's local and systemic defences. The classical quantitative threshold is more than 10 to the fifth power organisms per gram of tissue — below it, healthy tissue usually contains the contamination; above it, clinical infection is likely. Commit that number; it is a favourite viva stem.^[2]

The trap that explains why implant surgery is uniquely vulnerable: any foreign material — suture, mesh, prosthesis — lowers that threshold by several orders of magnitude. A stitch that would be harmless in clean tissue becomes a beachhead for bacteria.^[1]

The biofilm — 1000 times the resistance

Biofilm is the reason implant infections do not clear with antibiotics alone. Within hours of implantation, bacteria adhere to the surface of sutures, mesh, prosthetic joints, vascular grafts, and cardiac devices, and secrete an extracellular glycocalyx. Inside it they go metabolically quiescent as persister cells, hidden from neutrophils and up to 1000 times more resistant to antibiotics than their free-swimming planktonic cousins.^[1]

That single fact drives the whole of implant surgery: chronic biofilm infection often persists despite weeks of antibiotics and frequently needs implant removal for cure. It is why a prosthetic joint infection is a months-long problem, not a prescription.^[1]

The bug map — match the organism to the site

Eighty percent of SSIs come from the patient's own flora, which is why site-specific prophylaxis works. Know the flora by site, because the prophylaxis and the empiric therapy follow it.^[2]

• Skin — Staphylococcus aureus, coagulase-negative staphylococci, Corynebacterium. This is why clean surgery gets cefazolin.
• Upper GI and small bowel — streptococci, lactobacilli, Enterobacterales.
• Distal small bowel and colon — Enterobacterales (E. coli, Klebsiella, Enterobacter, Proteus), enterococci, and anaerobes (Bacteroides fragilis, Clostridium, Peptostreptococcus). This is why colorectal surgery adds metronidazole.
• Vagina — lactobacilli, group B Streptococcus, anaerobes, Enterobacterales.
• Exogenous (surgical team, theatre air, instruments) — typically S. aureus, coagulase-negative staphylococci, and in contaminated theatres Gram-negatives including Pseudomonas.
• Haematogenous — a distant focus (endocarditis, line infection, dental abscess) seeds the site; rare, but classic for early prosthetic joint infection.^[2]

The host response — and why oxygen is a drug

Tissue injury fires the inflammatory cascade, and neutrophils do the killing — but only if the tissue is oxygenated. Complement activates, fibrinogen becomes fibrin, platelets aggregate, and neutrophils and macrophages arrive to phagocytose bacteria through the respiratory or oxidative burst. That burst is critically dependent on tissue oxygen tension.^[1]

This is the mechanistic thread that ties the whole prevention bundle together. Subcutaneous oxygen tension correlates inversely with SSI risk, which is why warming, supplemental oxygen, fluid resuscitation, pain control (to stop catecholamine-driven vasoconstriction), and smoking cessation all work through the same final common pathway — delivering oxygen to a healing wound.^[10]

Meet the cardinal five — the signs of inflammation

SSI usually declares itself between postoperative days 3 and 10, though organ or space infections can surface weeks to months later. The local signs are the ancient five, and pain is usually the first. Cluster them once and they stay:^[1]

^[1]

Purulent drainage — and the differential of wound fluid

Purulent is the single most specific feature, and it is defined clinically, not in the lab. Thick, opaque, yellow, green, or brown, sometimes malodorous — and unmistakably different from the clear straw-coloured serous transudate of a seroma or the bloody drainage of a haematoma.^[3]

The bedside discriminator to nail at viva: serous means seroma, sanguineous means haematoma, purulent means SSI. If you cannot tell, aspirate it — but pus is pus, and by CDC criteria it makes the diagnosis on its own.^[3]

The dehiscence clock — "pink fluid" on day 5 to 8 is an emergency

Not every wound that gapes is the same emergency. Superficial dehiscence — separation of the skin edges — usually heals by secondary intention or delayed primary closure, and is a nuisance, not a crisis. Fascial or deep dehiscence is a different animal entirely.^[1]

The classic presentation to tattoo into memory: a patient around postoperative day 5 to 8 suddenly feels something "give" or "pop", and a serosanguineous "pink fluid" discharge soaks the dressing. That pink fluid is peritoneal fluid escaping through a failed fascia, and viscera may be visible underneath. This is a surgical emergency — cover the wound with sterile saline-soaked gauze, give broad-spectrum IV antibiotics, and return to theatre now for resuturing and management of any underlying SSI.^[1]

The recurring pitfall: a registrar who reassures himself that "it is just a seroma" when the fascia has let go. Seromas do not announce themselves with a pop on day 6. Pink fluid plus a pop is fascial dehiscence until the wound is explored.^[1]

The atypical presenters — when the loudest sign is silence

In the vulnerable patient, the inflammatory response is blunted and the signs whisper. Do not be reassured by the absence of fever or pus in these groups — a high index of suspicion is the only safe stance.^[1]

^[1]

The differential — not every red wound is SSI

A red, swollen, or draining wound has a long differential, and the discriminator is usually in the timing and the fluid. This is the table to reproduce when asked "what else could it be?"^[1]

^[1]

The killer in the differential — necrotising fasciitis

A low threshold for necrotising fasciitis is the single most important reflex on this list. Missed necrotising infection carries a mortality of 30 to 70 percent and progresses by the hour, not the day. The presenting triad to never ignore: pain out of proportion to the wound appearance, crepitus or dusky skin, and rapidly progressive systemic toxicity.^[1]

The LRINEC score (CRP, white cell count, haemoglobin, sodium, creatinine, glucose) helps risk-stratify, but a high clinical suspicion mandates immediate surgical exploration regardless of the score. Do not wait for imaging or cultures — the debridement is both the diagnostic and the therapeutic step. A wound that hurts more than it looks is necrotising until the fascia is seen.^[1]

The bedside round — inspect, probe, swab deep

Examination of a suspected SSI is a structured wound assessment, not a glance at the dressing. Remove the dressing with sterile technique under good light, and document each of these in the notes:^[1]

• Erythema — extent in centimetres beyond the wound edge, and whether well-demarcated or spreading.
• Warmth, swelling, and induration — measured and described, not "mild".
• Dehiscence depth — skin only, subcutaneous tissue, fascia, or full thickness with viscera visible.
• Discharge character and volume — serous, sanguineous, serosanguineous, or purulent; malodorous or not; volume per day.
• Surrounding skin — blistering, necrosis, crepitus, lymphangitis.
• Wound edge — undermining or tunnelling depth.
• Drains — site, effluent character, patency.^[1]

A wound probe gently introduced into a sinus or open cavity establishes depth and may reveal a hidden collection. Take a sterile swab from the deepest aspect, never the surface slough — the surface is colonised and will mislead you.^[1]

The ASEPSIS score and the Southampton grade

For surveillance and research, two named scoring systems quantify wound severity. The ASEPSIS wound score (Wilson et al. 1990) is the most widely used and is examiner-tested — reproduce the letters:^[1]

^[1]

The total, scored 0 to 665, classifies healing: 0 to 10 satisfactory, 11 to 20 disturbed, over 20 severe wound infection. The Southampton system runs a simpler 0 to VI grade — 0 heals by primary intention, I to IV track inflammation, haematoma, serous and purulent discharge, V is pus under the skin, and VI is a deep cavity with or without tissue breakdown.^[1]

Investigations — swab deep, image the cavity, and culture before antibiotics

The sampling principle that juniors break: culture the pus or the deep tissue, not the surface. The surface is colonised; a surface swab grows what lives there, not what infects the wound.^[1]

• Pus or deep tissue (not a surface swab) for Gram stain, culture, and sensitivity.
• Anaerobic transport if the wound is foul-smelling or anaerobes are suspected — anaerobes die in air.
• MRSA screen (nose, axilla, groin, perineum) on admission for high-risk procedures.^[13]

Bloods track severity and guide response. In a meta-analysis of nearly 2000 patients after abdominal operations, CRP measured on postoperative day 4 had the highest diagnostic accuracy for infectious complications (area under the curve 0.76), and a normal day-4 CRP reliably excluded them — negative predictive value 84 percent.^[21] A CRP that fails to fall or rises after the expected early postoperative peak should raise suspicion of an SSI and trigger a careful wound review.

Take two sets of blood cultures — peripheral, separate venepunctures, before antibiotics — in any patient with fever over 38.5 degrees Celsius, systemic sepsis, or immunocompromise. Antibiotic susceptibility results then guide de-escalation; request MRSA, ESBL, and carbapenemase status as appropriate.^[1]

Imaging is chosen by the question you are asking. Bedside ultrasound finds superficial, abdominal-wall, and pelvic collections and can guide drainage — useful in children, pregnant women, and the critically ill. CT with IV contrast and water-soluble oral and rectal contrast is the gold standard for intra-abdominal and pelvic collections, anastomotic leak, and gas-forming infection — use water-soluble, never barium, if perforation or leak is suspected. MRI is preferred for spinal hardware, prosthetic joint, and extremity soft-tissue infection, with high sensitivity for osteomyelitis. Nuclear medicine (white-cell-labelled scan, FDG-PET or CT) is reserved for chronic prosthetic joint infection when conventional imaging is indeterminate.^[1]

For organ or space infections, special tests close the diagnosis: a joint aspirate with synovial white cells over 3000 per microlitre and neutrophil predominance suggests prosthetic joint infection, and multiple deep tissue biopsies (3 to 6) at revision arthroplasty feed the modified Birmingham criteria. A sinogram — contrast injected into a sinus tract — may delineate a deep collection or a connection to a viscus.^[1]

Resuscitation — sepsis first, source control with it

Enlarge

Most SSIs are not immediately life-threatening — but a deep or organ or space SSI presenting with sepsis is a time-critical emergency. Run the Surviving Sepsis Campaign approach, and do not let source control wait for "stability" that will not come without it.^[24]

^[24]

The sentence that earns marks and saves lives: source control is not a substitute for antibiotics, and antibiotics are not a substitute for source control — both are required. Do not delay source control waiting for stability in necrotising infection, fascial dehiscence with exposed viscera, or an uncontrolled leak.^[1]

The management ladder — depth decides the move

Once resuscitated, management follows the depth, and the depth alone. Three steps, three depths, three different first moves.^[1]

Step 1 — Superficial incisional SSI

• Open the wound — remove the sutures or staples over the infected segment and let it drain.
• Send pus or deep tissue (not a surface swab) for Gram stain, culture, and sensitivity.
• Irrigate with normal saline and pack lightly with saline-soaked gauze; change the dressing daily and document dimensions, exudate, and tissue type.
• Antibiotics only if there is surrounding cellulitis or systemic signs — choose agent and route against the likely organisms and the culture results, per local policy.
• Re-evaluate at 48 hours — if not improving, reconsider the diagnosis (deeper infection? resistant organism? necrotising?), escalate to imaging, IV antibiotics, and surgical review.^[1]

Step 2 — Deep incisional SSI

• Open the entire wound, not just the infected segment.
• Surgical debridement of all necrotic tissue, slough, and non-viable fascia; explore for and drain any associated collection.
• Daily surgical dressing change, or a vacuum dressing.
• IV antibiotics: an antistaphylococcal beta-lactam for MSSA; the IDSA MRSA guideline recommends vancomycin, with explicit dosing and monitoring guidance, for MRSA infection or beta-lactam allergy; broaden for a polymicrobial or GI source per local policy.^[23]
• Image to exclude extension to organ or space (CT abdomen and pelvis).
• De-escalate to targeted therapy once sensitivities are back, and keep the course as short as remains effective.

Step 3 — Organ or space SSI

• Source control is paramount: percutaneous image-guided drainage (CT or ultrasound) for accessible collections — preferred over surgery where feasible; re-operation for collections not amenable to percutaneous drainage, for anastomotic leak with peritonitis, for retained necrotic tissue, or for failed percutaneous drainage.
• Broad-spectrum IV antibiotics as for the resuscitation bundle; de-escalate to targeted therapy on cultures.
• Manage the underlying cause — an anastomotic leak may need resection and stoma, a prosthetic joint infection may need one-stage or two-stage revision, mediastinitis may need rewiring and flap cover.
• Duration 7 to 14 days for most organ or space infections; 4 to 6 weeks for osteomyelitis, mediastinitis, and prosthetic joint infection, with infectious diseases input.^[1]

Negative-pressure wound therapy — minus 125 mmHg, and when to use it

NPWT (the VAC) delivers continuous negative pressure, usually minus 125 mmHg (range 50 to 175), to an open wound. It removes exudate, increases local blood flow, reduces oedema, promotes granulation, contracts the wound edge, and cuts dressing-change frequency. Indications: open abdomen, dehisced wounds, large defects after debridement, complex perineal wounds after abdominoperineal resection, diabetic foot ulcers, and burns.^[4]

The growing use is prophylactic closed-incision NPWT (ciNPWT) on high-risk closed incisions — obese patients, midline laparotomy, sternotomy in obese diabetics, and groin incisions after vascular surgery.^[4]

Antibiotic duration — short is the new normal

The modern principle is the shortest effective course, de-escalated as soon as sensitivities return. Prolonged antibiotics select resistance and Clostridioides difficile without added benefit.^[1]

• Superficial with cellulitis — 5 to 7 days oral.
• Deep — 7 to 14 days IV, transition to oral once afebrile and improving.
• Organ or space with source control — 4 to 7 days after source control for most intra-abdominal infections (short courses are equivalent to longer); 4 to 6 weeks IV for osteomyelitis, mediastinitis, and prosthetic joint infection.
• De-escalate as soon as sensitivities are available; engage antimicrobial stewardship.^[1]

The escalation triggers — when to worry at 48 to 72 hours

Failure to improve within 48 to 72 hours of appropriate therapy is a signal, not a setback to wait out. Reconsider the diagnosis, repeat the imaging, and seek surgical review. Worsening pain, spreading erythema, new crepitus, or systemic deterioration mean suspect necrotising infection or an uncontrolled source — emergency surgical review, not another dressing change. New organ dysfunction means ICU.^[1]

The named subtypes that bite

Orthopaedic prosthetic joint infection

Biofilm is the defining feature, and biofilm is why retention usually fails for chronic infection. The commonest organisms are coagulase-negative staphylococci and S. aureus, with Streptococcus, Enterococcus, Gram-negatives, and anaerobes in the mix.^[1]

Diagnosis is clinical (pain, swelling, sinus tract) plus a raised CRP and ESR, a joint aspirate (synovial white cells over 3000 per microlitre with neutrophil predominance is suggestive), and multiple deep tissue biopsies at revision surgery — 3 to 6 samples, read against the modified Birmingham criteria. Management splits by timing: acute infection (under 3 weeks post-op) gets DAIR — Debridement, Antibiotics, Irrigation, and Retention of the implant — plus IV antibiotics such as rifampicin with a fluoroquinolone for staphylococci, for 6 weeks. Chronic infection gets two-stage exchange — remove the implant, place an antibiotic-loaded cement spacer, give 6 weeks of IV antibiotics, then reimplant — which remains the gold standard. One-stage exchange is an option in selected centres. If the implant cannot be removed and the patient is not fit for surgery, suppressive antibiotics continue for life.^[1]

Colorectal surgery — day-5 to day-7 fever is a leak until proven otherwise

The commonest organ or space SSI after colorectal surgery is an anastomotic leak with pelvic abscess. The organisms are enteric — E. coli, Klebsiella, Enterobacter, enterococci, and Bacteroides fragilis — which is why prophylaxis is a cephalosporin (cefuroxime or ceftriaxone) plus metronidazole.^[1]

The trap that costs lives: fever, tachycardia, and ileus after a colorectal anastomosis around day 5 to 7 is an anastomotic leak until proven otherwise, not "a minor ileus". Image with CT using water-soluble oral and rectal contrast. Generalised peritonitis means emergency re-operation with diversion (Hartmann's); a localised pelvic abscess may drain percutaneously.^[1]

Prevention has reversed itself in the last decade: combined mechanical and oral antibiotic bowel preparation (polyethylene glycol prep plus oral neomycin and metronidazole) reduces SSI more than IV antibiotics alone, overturning the old teaching that bowel prep was unnecessary.^[1]

Caesarean section — pre-incision, not cord-clamp

Caesarean birth carries a higher risk of surgical site infection than vaginal birth, which is why preventive measures matter so much in this population.^[14]

The practice change every candidate must name: the prophylactic IV antibiotic is given before skin incision, not after cord clamping. The Mackeen Cochrane review (10 trials, 5041 women) found pre-incision administration reduced composite maternal infectious morbidity (risk ratio 0.57), endometritis (risk ratio 0.54), and wound infection (risk ratio 0.59), with no clear difference in neonatal sepsis — and the CDC 2017 guideline likewise recommends antimicrobial prophylaxis before skin incision for caesarean section.^[14][1]

Endometritis is the organ or space equivalent — fever, uterine tenderness, and foul lochia — treated with IV clindamycin plus gentamicin (or co-amoxiclav).^[17]

Cardiac surgery — mediastinitis and the decolonisation win

Deep SSI after sternotomy is mediastinitis, and it carries a mortality of 10 to 40 percent. The organisms are S. aureus (especially in nasal carriers), coagulase-negative staphylococci, and Gram-negatives.^[13]

The prevention win to cite by name: rapid screening for S. aureus nasal carriage, with carriers decolonised using mupirocin nasal ointment and chlorhexidine soap. The Bode NEJM 2010 trial showed this cut hospital-associated S. aureus infection from 7.7 to 3.4 percent (relative risk 0.42), with the largest effect on deep SSI (relative risk 0.21); the 2017 Cochrane review, however, located only two eligible trials and concluded the evidence remains uncertain.^[13][15]

Prophylaxis follows the standard timing rule — CDC 2017 requires bactericidal concentrations in serum and tissues at the time of incision, and advises that for clean and clean-contaminated procedures no additional prophylactic doses be given after the incision is closed, even with a drain. In known MRSA carriage or beta-lactam allergy, IDSA guidance makes vancomycin, with attention to dosing and monitoring, the agent of choice for MRSA infection.^[1][23]

Vascular graft infection

Early graft infection is S. aureus and Gram-negatives; late infection is indolent coagulase-negative staphylococci, months to years later. The spectre is graft-enteric erosion — an aorto-enteric fistula presenting with a herald upper GI bleed. Diagnose with CT angiography, and a tagged white-cell scan if indeterminate.^[1]

Management is graft excision plus either extra-anatomic bypass (axillo-bifemoral) or in-situ replacement with rifampicin-soaked or silver-coated Dacron, a biological (cadaveric) graft, or autogenous vein. If the graft is retained, suppressive antibiotics continue for life.^[1]

Implant and mesh infections — biofilm decides the strategy

Biofilm is the central problem, so the timing of infection dictates whether you can keep the implant. Acute infection (under 3 weeks) may respond to DAIR plus targeted IV antibiotics. Chronic infection usually needs implant removal, antibiotics, and delayed reimplantation. Mesh infection after hernia repair can be tried with conservative antibiotics, but persistent infection means mesh removal — often partial.^[1]

The prevention bundle — seven pillars, one mantra

SSI is preventable, and the bundle is the proof. Every pillar has a landmark trial behind it, and together they are the single highest-yield topic in surgical infection. Learn the bundle as one breath and the evidence behind each pillar.^[1]

^{[1] [6] [10] [16] [11] [12] [8]}

Classen 1992 — the pre-incision gold standard

One NEJM paper underpins every "antibiotics before incision" rule on the planet. Classen et al. plotted SSI rate against the timing of prophylactic antibiotics in 2847 patients undergoing elective clean or clean-contaminated surgery, and the curve was unmistakable.^[6]

^[6]

The re-dosing principle follows from pharmacokinetics: tissue levels fall as the operation lengthens and as blood is lost, so long cases and major haemorrhage require intraoperative re-dosing under local prophylaxis policy. CDC 2017 sets the outer boundary: for clean and clean-contaminated procedures, no additional prophylactic antimicrobial doses should be given after the surgical incision is closed, even in the presence of a drain.^[1]

Kurz, Greif, and Belda — warm and oxygenated

Two more NEJM or JAMA papers complete the physiology story: keep the patient warm, and keep the wound oxygenated. Both work through the same mechanism — tissue oxygen tension drives the neutrophil oxidative burst.^[10]

^{[10] [11]}

The oxygen controversy is named calmly: PROXI (2009) found no benefit, so the evidence is not unanimous. Current guidance keeps 80 percent FiO2 for patients with normal oxygenation because the downside is trivial and the upside, when present, is real.^[12]

Bode, Liu, and Huang — decolonisation in the right patient

For S. aureus, the nose is the reservoir, and clearing it prevents the SSI. The evidence comes in three shapes — a targeted RCT, a Cochrane review, and a universal-decolonisation ICU trial.^[13]

^[13]

The Liu 2017 Cochrane review struck a cautious note — it located only two eligible trials and concluded that the benefits and harms of nasal decontamination in S. aureus carriers remain uncertain.^[15] The Troeman 2023 cohort quantified the stakes: preoperative S. aureus colonisation carries an adjusted hazard ratio of 4.38 for postoperative S. aureus SSI or bacteraemia, which is exactly why screening the high-risk patient pays.^[20]

The Huang 2013 NEJM trial took the logic one step further — in the ICU, universal decolonisation (mupirocin and chlorhexidine for every patient, without screening) reduced MRSA clinical isolates and bacteraemia more than targeted screening and isolation. The lesson for the ward is selective screening; the lesson for the ICU is sometimes to treat everyone.^[19]

Haynes 2009 — the checklist that travels

The WHO Surgical Safety Checklist is the cheapest, most portable intervention on the list, and it works everywhere it is used. In a global cohort of over 7000 patients, Haynes et al. showed it cut inpatient complications from 11 percent to 7 percent and mortality from 1.5 percent to 0.8 percent — in hospitals rich and poor alike.^[8]

^[8]

Tanner 2021 — clip, do not shave

The razor makes micro-lacerations that seed the wound; the clipper does not. The Tanner 2021 Cochrane review settled this cleanly: there is no difference in SSI between clipping and no hair removal at all, but shaving is associated with a higher SSI rate than clipping. If hair must be removed, use clippers, not razors.^[16]

Hadiati 2020 — chlorhexidine-alcohol for caesarean skin prep

For skin preparation, chlorhexidine-alcohol wins on rapid, persistent activity. The Hadiati 2020 Cochrane review found no clear difference between antiseptic agents overall for caesarean skin prep, but chlorhexidine-alcohol is generally preferred for its rapid onset and persistence — and it is the choice that maps onto the broader CDC and WHO preference.^[17]

The named guidelines — who says what

Four documents set the global standard; know them by author and year. The CDC 2017 Guideline for the Prevention of SSI (Berríos-Torres et al.) superseded the 1999 CDC or HICPAC guideline (Mangram) and gives the high-priority recommendations on antibiotics, glycaemic control, normothermia, oxygenation, and hair removal that the bundle is built from.^[1]

The WHO Global Guidelines for SSI Prevention (Allegranzi et al., 2016) came in two parts — 13 pre-operative recommendations and 16 intra-operative and post-operative recommendations — and was the first guideline to address low- and middle-income countries explicitly and to make recommendations on glycaemic control, anaesthetic agents, and oxygenation. The ASHP, IDSA, SIS, and SHEA surgical prophylaxis guideline (Bratzler et al. 2013) is the procedure-specific antibiotic reference — agent, dose, timing, duration, and re-dosing.^[4][5]

Controversies — name them calmly

Three live debates recur in exams, and the safe answer is to name the uncertainty and quote the current guidance.^[4]

• Optimal oxygen concentration — PROXI (2009) was neutral, but WHO and CDC still recommend 80 percent FiO2 intraoperatively and in early recovery for patients with normal oxygenation.^[4]
• Mechanical bowel preparation — once thought useless, now vindicated: combined mechanical and oral antibiotic bowel preparation reduces SSI more than IV antibiotics alone in elective colorectal surgery.^[1]
• Routine vancomycin versus cefazolin prophylaxis — cefazolin remains first-line; vancomycin is added for known MRSA carriers, beta-lactam allergy, or high local MRSA prevalence; routine dual coverage is not recommended because of nephrotoxicity and selection pressure.^[7]
• Antibiotic-impregnated suture (triclosan-coated Vicryl Plus) — a modest SSI reduction in meta-analyses; WHO suggests use.^[4]
• Duration of prophylaxis — a single pre-incision dose is as effective as 24-hour coverage for most procedures; prolonged prophylaxis selects resistance and C. difficile.^[1]

Special populations — how the calculus shifts

Diabetes mellitus

Poorly controlled diabetes is a modifiable SSI risk, and the perioperative target is defined. The CDC 2017 guideline recommends implementing glycaemic control during surgery using blood glucose target levels under 200 mg per dL (about 11 mmol per litre) — and the same guideline confirms that blood transfusion should not be withheld from surgical patients as a means of preventing SSI. Involve the anaesthetic and diabetes teams well before the date rather than chasing high sugars on the morning of surgery.^[1]

Obesity

Rising BMI is independently associated with SSI — adjusted hazard ratio 1.05 per unit increase in the ASPIRE-SSI cohort — and prophylaxis dosing matters: most guidelines recommend a 3 g cefazolin dose for patients weighing 120 kilograms or more, although a retrospective cohort found no significant excess of SSI at or over 120 kilograms in patients given 2 g (9.8 versus 5.0 percent, not significant), so the clinical evidence base remains thin.^[20][22]

Immunosuppressed patients

Atypical and opportunistic organisms — Candida, Aspergillus, mycobacteria (M. abscessus, M. chelonae), Pseudomonas — and a blunted inflammatory response that hides them. Keep a low threshold for imaging and biopsy, involve infectious diseases and microbiology early, and cover broadly empirically (meropenem plus vancomycin, plus or minus an antifungal) until the organism is identified.^[1]

Elderly

A blunted inflammatory response means atypical presentation — confusion, hypothermia, hypoglycaemia, falls — and higher mortality from comorbidity. Prioritise delirium prevention: optimise pain control, sleep, hydration, and mobility, and minimise sedatives.^[1]

Pregnancy and caesarean

Pre-incision (not cord-clamp) prophylaxis is the standard for caesarean section. The Mackeen Cochrane review found preoperative administration reduced endometritis (risk ratio 0.54) and wound infection (risk ratio 0.59) with no clear difference in neonatal sepsis, and the CDC 2017 guideline recommends antimicrobial prophylaxis before skin incision in caesarean section.^[14][1]

Paediatrics

Dose by weight in children, and keep radiation exposure down. Antibiotic prophylaxis is weight-based per paediatric protocols — follow local paediatric antimicrobial guidance for agent, dose, and interval. Prefer ultrasound where it answers the question, and involve the parents in care and consent.^[1]

MRSA carriers

Screen for S. aureus nasal carriage before high-risk surgery and decolonise carriers. Bode 2010: rapid screening plus mupirocin nasal ointment and chlorhexidine soap cut hospital-associated S. aureus infection from 7.7 to 3.4 percent (relative risk 0.42), with the largest effect on deep SSI (relative risk 0.21). Preoperative carriage independently raises S. aureus SSI risk over four-fold (adjusted hazard ratio 4.38, Troeman 2023). Where MRSA must be covered, IDSA guidance recommends vancomycin with explicit dosing and monitoring.^[13][20][23]

Regional deltas — the same bundle, different constraints

The diagnostic and management framework — CDC depth classes, the prevention bundle, source control — is globally consistent. What changes is the resource envelope around it.^[4]

^[4]

How patients come to harm — the preventable list

These are the failures that turn a clean operation into a long admission, and most are preventable.^[1]

• A missed necrotising fasciitis read as cellulitis and treated with antibiotics while the fascia dies — the preventable death.
• Prophylaxis given after incision — the single most common breach, and the one Classen 1992 quantified: 0.6 percent SSI with pre-incision dosing versus 1.4 to 3.3 percent once surgery has begun or later.^[6]
• A fascial dehiscence written off as a seroma when the pink fluid and the pop were the giveaway.
• A fever after colorectal anastomosis treated as "minor ileus" instead of a leak until proven otherwise.
• Under-dosed prophylaxis in the obese patient — most guidelines recommend 3 g cefazolin at 120 kilograms or more.^[22]
• A surface swab growing colonisers, while the deep pus that would have guided therapy was never sent.
• A hypothermic patient left cold because "the theatre was busy", when warming cut SSI from 19 to 6 percent in the Kurz trial.^[10]
• An S. aureus carrier sent to sternotomy without screening or decolonisation, when mupirocin and chlorhexidine cut deep S. aureus SSI by 79 percent (relative risk 0.21).^[13]

The mantra, and the mnemonics

^{[1] [6] [10] [11] [12] [1]}

The mantra: about half of SSIs are preventable — antibiotics timed before incision, normothermia, glucose control, clip not shave, oxygen, alcohol-based prep, checklist. Say it as one breath and you have the prevention marks.^[1][8]

Ward-round test — four stems, thirty seconds each

Stem 1 — the day-7 colectomy wound (answer)ShowHide

The 64-year-old diabetic from the opening vignette, day 7 after sigmoid colectomy, with an erythematous weeping lower wound, low-grade fever, and a rising CRP. The SHO asks whether to start oral flucloxacillin. What is the right first move? Model: First, confirm the depth and exclude a collection — this is the step the SHO is about to skip. Inspect and probe the wound, send the deep pus for culture, and image with CT if there is any concern about an organ or space component (an anastomotic leak is the danger in this patient). If it is genuinely a superficial incisional SSI, open the wound, pack it, and give targeted antibiotics only if there is surrounding cellulitis or systemic signs, guided by the culture result. Re-evaluate within 48 hours. Starting antibiotics without opening the wound and without excluding a deeper collection is the trainee error.^[1]

Stem 2 — the pink fluid on day 6 (answer)ShowHide

A patient six days after a laparotomy feels something "pop" while coughing, and the dressing soaks through with pink fluid. What happened, and what do you do in the next 15 minutes? Model: This is fascial dehiscence until proven otherwise — the pop and the serosanguineous pink fluid are pathognomonic, and viscera may be visible underneath. Cover the wound with sterile saline-soaked gauze, give broad-spectrum IV antibiotics, resuscitate, and return to theatre now for resuturing and management of any underlying SSI. Do not reassure yourself it is a seroma — seromas do not announce themselves with a pop on day 6.^[1]

Stem 3 — the wound that hurts more than it looks (answer)ShowHide

A post-operative wound looks only mildly erythematous, but the patient is in severe pain, the skin over it is dusky, and you feel crepitus. The CRP is high. What is the diagnosis and the next step? Model: This is necrotising fasciitis until proven otherwise — pain out of proportion, crepitus, dusky skin, and systemic toxicity are the classic tetrad, and the LRINEC score will be raised. Do not wait for imaging or cultures. The next step is emergency surgical exploration and debridement — the operation is both diagnostic and therapeutic, and mortality climbs by the hour. Broad-spectrum IV antibiotics run alongside, but the knife is the treatment.^[1]

Stem 4 — the MRSA-positive cardiac patient (answer)ShowHide

A patient listed for elective coronary artery bypass grafting screens positive for MRSA nasal carriage at pre-assessment. What do you do before the operation, and what prophylaxis do you give on the day? Model: Decolonise before surgery — rapid screening plus mupirocin nasal ointment and chlorhexidine body wash cut S. aureus infection from 7.7 to 3.4 percent (relative risk 0.42) and deep SSI by 79 percent (relative risk 0.21) in the Bode trial of cardiothoracic and orthopaedic carriers. On the day, ensure prophylaxis covers MRSA per local policy — IDSA guidance recommends vancomycin, with explicit dosing and monitoring, for MRSA — and time every dose so bactericidal tissue levels are present at incision.^[13][23]

References24ShowHide

1. [1]Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 JAMA Surg, 2017.PMID 28467526
2. [2]Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee Am J Infect Control, 1999.PMID 10196487
3. [3]Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections Infect Control Hosp Epidemiol, 1992.PMID 1334988
4. [4]Allegranzi B, Zayed B, Bischoff P, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective Lancet Infect Dis, 2016.PMID 27816414
5. [5]Allegranzi B, Bischoff P, de Jonge S, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective Lancet Infect Dis, 2016.PMID 27816413
6. [6]Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection N Engl J Med, 1992.PMID 1728731
7. [7]Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery Am J Health Syst Pharm, 2013.PMID 23327981
8. [8]Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population N Engl J Med, 2009.PMID 19144931
9. [9]Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections N Engl J Med, 2014.PMID 24670166
10. [10]Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group N Engl J Med, 1996.PMID 8606715
11. [11]Greif R, Akça O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection N Engl J Med, 2000.PMID 10639541
12. [12]Belda FJ, Aguilera L, García de la Asunción J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial JAMA, 2005.PMID 16249417
13. [13]Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus N Engl J Med, 2010.PMID 20054045
14. [14]Mackeen AD, Packard RE, Ota E, et al. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery Cochrane Database Syst Rev, 2014.PMID 25479008
15. [15]Liu Z, Norman G, Iheozor-Ejiofor Z, et al. Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers Cochrane Database Syst Rev, 2017.PMID 28516472
16. [16]Tanner J, Melen K Preoperative hair removal to reduce surgical site infection Cochrane Database Syst Rev, 2021.PMID 34437723
17. [17]Hadiati DR, Hakimi M, Nurdiati DS. Skin preparation for preventing infection following caesarean section Cochrane Database Syst Rev, 2020.PMID 32580252
18. [18]Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English hospitals J Hosp Infect, 2005.PMID 15866006
19. [19]Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection N Engl J Med, 2013.PMID 23718152
20. [20]Troeman DPR, Hazard D, Timbermont L, et al. Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization JAMA Netw Open, 2023.PMID 37906196
21. [21]Adamina M, Steffen T, Tarantino I, et al. Meta-analysis of the predictive value of C-reactive protein for infectious complications in abdominal surgery Br J Surg, 2015.PMID 25776855
22. [22]Hussain Z, Curtain C, Mirkazemi C, et al. Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients? Obes Surg, 2019.PMID 30267229
23. [23]Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis, 2011.PMID 21208910
24. [24]Evans L, Rhodes A, Alhazzani W, et al. Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021 Crit Care Med, 2021.PMID 34643578